Literature DB >> 6134578

Immunoreactive somatostatin and vasoactive intestinal polypeptide in adrenal pheochromocytoma. An immunochemical and ultrastructural study.

T Sano, H Saito, H Inaba, K Hizawa, S Saito, A Yamanoi, Y Mizunuma, M Matsumura, M Yuasa, K Hiraishi.   

Abstract

An adrenal pheochromocytoma producing somatostatin (SRIF) and vasoactive intestinal polypeptide (VIP) in a 17-year-old boy is presented. High concentrations of immunoreactive (IR)-SRIF were found in plasma taken from the antecubital vein (31.0-33.0 pg/ml) and the inferior caval vein near the tumor (54.6 pg/ml), but after removal of the tumor the values became normal (11.0-15.2 pg/ml). In two portions of the resected tumor, considerable but different amounts of IR-SRIF (151.7 and 12.1 ng/g wet wt) and IR-VIP (13.0 and 5.5 ng/g wet wt) were demonstrated with size heterogeneities. Immunohistochemically, many IR-SRIF cells and a few IR-VIP cells were observed, but no cell reacting with both anti-SRIF and anti-VIP sera was found. Electronmicroscopically, many tumor cells had catecholamine-like granules (250-350 nm in diameter) while some others had VIP-like granules (110-140 nm in diameter). However, no granules resembling the SRIF granules seen in the pancreatic D cells were found. This seems to be the first report of an adrenal pheochromocytoma that produces SRIF and VIP simultaneously. It provides information on the histogenesis of hormone-producing neurogenic tumors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134578     DOI: 10.1002/1097-0142(19830715)52:2<282::aid-cncr2820520215>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Adrenal ganglioneuroma-pheochromocytoma secreting vasoactive intestinal polypeptide.

Authors:  L N Contreras; D Budd; T S Yen; C Thomas; J B Tyrrell
Journal:  West J Med       Date:  1991-03

2.  Plasma gut hormone levels in 37 patients with pheochromocytomas.

Authors:  A I Vinik; B Shapiro; N W Thompson
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

Review 3.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

4.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

5.  Watery diarrhea syndrome due to an adrenal pheochromocytoma secreting vasoactive intestinal polypeptide.

Authors:  S G Sackel; J E Manson; S J Harawi; R Burakoff
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

Review 6.  Watery diarrhea, hypokalemia and achlorhydria syndrome due to an adrenal pheochromocytoma.

Authors:  Shin-ichi Ikuta; Chiaki Yasui; Masahiro Kawanaka; Tsukasa Aihara; Hidenori Yoshie; Hidenori Yanagi; Masao Mitsunobu; Ayako Sugihara; Naoki Yamanaka
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

7.  Measurement of catecholamines, met-enkephalin, somatostatin and substance P-like immunoreactivities in 12 human pheochromocytomas.

Authors:  E Baldi; M L De Feo; P Geppetti; V Carlà; M Maggi; C Pupilli; M G Spillantini; A Brocchi; M Mannelli
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

8.  Immunoreactive somatostatin in Warthin's tumor.

Authors:  Y Hayashi; H Saito; S Saito; T Yanagawa; H Yoshida; Y Yura; M Sato
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

9.  Multiple peptide production and presence of general neuroendocrine markers detected in 12 cases of human phaeochromocytoma and in mammalian adrenal glands.

Authors:  G W Hacker; A E Bishop; G Terenghi; I M Varndell; J Aghahowa; K Pollard; J Thurner; J M Polak
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

10.  Somatostatin-secreting Pheochromocytoma Mimicking Insulin-dependent Diabetes Mellitus.

Authors:  Hiroyuki Hirai; Sanae Midorikawa; Shinichi Suzuki; Hironobu Sasano; Tsuyoshi Watanabe; Hiroaki Satoh
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.